Clinical Trial Update: Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating CKD-314 for COVID-19 pneumonia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• CKD-314

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: COVID-19 Pneumonia | Phase 3 | Status: UNKNOWN